Nuventra Pharma Sciences, a United States-based clinical pharmacology consulting company, has named Daniel Roy, MHA as its new president, it was reported on Tuesday.
Roy joined the company in 2014 as manager of Marketing and Corporate Communication. He has served in various roles of increasing responsibility including senior director of Business Development and Marketing, and most recently as vice president of Corporate Strategy and Business Development. He has 16 years of experience in leadership, marketing, and business development. He will continue to serve as the company's chief executive officer.
Roy graduated from Ohio University with a Master of Healthcare Administration and acquired a Bachelor of Arts degree in Communication from East Carolina University.
Avidity Biosciences names new Directors
Indonesia's food and drugs regulator approves China's Sinovac COVID-19 with 65.3% efficacy
Maruho names new president and CEO
BioTheryX names new president and CEO
Clerics of Indonesia's Muslim council declare Sinovac's COVID-19 vaccine halal
Silver Named to TScan Therapeutics Board of Directors
Viking Therapeutics names new CFO and COO
European Commission Authorizes COVID-19 Vaccine Moderna in Europe
McMillan Named Chief Technical Officer at SwanBio Therapeutics
Jnana Therapeutics Names Chen to Board of Directors, Susztak to Scientific Advisory Board
Entrada Therapeutics Names Kim to its Board of Directors
Nuventra Pharma Sciences names new president
Nektar Therapeutics names interim chief medical officer, head of Development